Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection

Anionic pulmonary surfactant lipid regulation of innate immunity

(2012) Mari Numata et al.   Expert Review of Respiratory Medicine

Phosphatidylglycerol Suppresses Influenza A Virus Infection

(2011) Mari Numata et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Pulmonary Surfactant Phosphatidylglycerol InhibitsMycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages

(2011) Pitchaimani Kandasamy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c Mice

(2011) K. L. Stokes et al.   JOURNAL OF VIROLOGY

Lung surfactant DPPG phospholipid inhibits vaccinia virus infection

(2010) Julien Perino et al.   ANTIVIRAL RESEARCH

Pharmacotherapy of respiratory syncytial virus infection

(2010) Robert C Welliver   CURRENT OPINION IN PHARMACOLOGY

Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2

(2009) Koji Kuronuma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction

(2009) M. L. Moore et al.   JOURNAL OF VIROLOGY

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

(2009) M. Numata et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA